Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
PLoS One. 2021 Jul 22;16(7):e0254840. doi: 10.1371/journal.pone.0254840. eCollection 2021.
Nocardia species belong to the aerobic actinomycetes group of bacteria which are gram-positive and partially acid-fast Bacilli. These bacteria may sometimes be associated with nosocomial infections. Nocardia diseases are not required to be reported to public health authorities in Iran. Hence, the present study was designed to determine the prevalence of human Nocardia spp. in Iran by using a systematic review and meta-analysis according to the preferred reporting items for systematic reviews and meta-Analyses statement.
The data of the prevalence of Nocardia species were collected from databases such as Embase, PubMed/MEDLINE via Ovid, Web of Science, Scopus and Google Scholar as well as national Iranian databases, including SID, Magiran. Analyses were conducted by STATA 14.0.
The meta-analyses showed that the proportion of Nocardia spp. in Iranian studies varied from 1.71(1.17, 2.24) to 0.46(0.09, 0.83). N. asteroides (21% [95% CI 1.17, 2.24]), N. cyriacigeorgica (17% [95% CI 0.99, 1.77]), N. facanica (10% [95% CI 0.75, 1.00]) were considered to be common causative agents.
Our study presents that despite the fact that Nocardia spp. are normally are saprophytic organisms, are currently accounts as emerging pathogens due to an increase in immunocompromised patients among Iranian populations. Considering our results, the establishment of advanced diagnostic facilities for the rapid detection of Nocardia infections are required for optimal therapeutic strategies of Nocardia spp. in Iran. Our findings could help the programmatic management of the disease within the context of Nocardia control programs.
诺卡氏菌属属于需氧放线菌组的细菌,革兰氏阳性,部分为抗酸性杆菌。这些细菌有时可能与医院获得性感染有关。在伊朗,不需要向公共卫生当局报告诺卡氏菌病。因此,本研究旨在根据系统评价和荟萃分析的首选报告项目,通过系统评价和荟萃分析来确定伊朗人类诺卡氏菌属的流行率。
从 Embase、PubMed/MEDLINE 通过 Ovid、Web of Science、Scopus 和 Google Scholar 等数据库以及包括 SID、Magiran 在内的伊朗国家数据库中收集了诺卡氏菌属的流行率数据。使用 STATA 14.0 进行分析。
荟萃分析显示,伊朗研究中诺卡氏菌属的比例从 1.71(1.17, 2.24)到 0.46(0.09, 0.83)不等。N. asteroides(21%[95%CI 1.17, 2.24])、N. cyriacigeorgica(17%[95%CI 0.99, 1.77])、N. facanica(10%[95%CI 0.75, 1.00])被认为是常见的病原体。
我们的研究表明,尽管诺卡氏菌属通常是腐生菌,但由于伊朗人群中免疫功能低下的患者增加,它们目前被认为是新兴的病原体。考虑到我们的结果,需要建立先进的诊断设施来快速检测诺卡氏菌感染,以便在伊朗制定诺卡氏菌属的最佳治疗策略。我们的发现可以帮助在诺卡氏菌控制计划的背景下对该疾病进行规划管理。